Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
biotech
cancer
clinical trials
fda
national top stories
new york
new york blog main
new york top stories
agios pharmaceuticals
boston
cancer drugs
community oncology alliance
crispr
cvs health
cystic fibrosis
cystic fibrosis foundation
david e. shaw
dna sequencing
drew pardoll
drug discovery
drugs
electronic health records
enasidenib
flatiron health
general atlantic
gilead sciences
hepatitis c
incivek
investing
ipo
ivosidenib
jeff leiden
jens reuter
johns hopkins bloomberg-kimmel institute for cancer immunotherapy
kayldeco
maine cancer center initiative
What
helped
3
×
medicines
3
×
aim
boost
cancer
cf
change
community
company’s
course
crisis
cystic
developer
development
diagnostics
discover
docs
experimental
fibrosis
flatiron
force
growing
handiwork
immunotherapy
internal
ipo
jeff
landscape
leiden
new
number
oneoncology
past
pharmaceuticals
pipeline
profitable
roles
scan
schrödinger
schrödinger’s
Language
unknown
unset
Current search:
helped
×
medicines
×
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
